Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis
ABSTRACT Background Multiple studies have demonstrated the intracranial efficacy of immune checkpoint inhibitors (ICI) +/− chemotherapy. The efficacy of chemoimmunotherapy compared to ICI alone in patients with metastatic NSCLC and brain metastases (BM) remains unknown. Methods A systematic review a...
Saved in:
Main Authors: | Lauren Julia Brown, Nicholas Yeo, Harriet Gee, Benjamin Y. Kong, Eric Hau, Inês Pires daSilva, Adnan Nagrial |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.15510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung Metastases to the Heart with Atypical Clinical Manifestations of Cardiac Failure
by: Natalia HYRIAVENKO, et al.
Published: (2023-03-01) -
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01) -
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01) -
Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
by: Irina Surovtsova, et al.
Published: (2025-12-01) -
Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases
by: Yuji Miyamoto, et al.
Published: (2025-01-01)